Pharmacists in Beverly Hills, TX Accepting Medicare
5 Pharmacists found. Showing 1 - 5
 Arthur F Smith Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 S Valley Mills Dr, Beverly Hills, TX 76711 Phone: 254-752-3986 |
Mark Rasband, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 S Valley Mills Dr, Beverly Hills, TX 76711 Phone: 254-752-3986 |
 Das Hey Kang Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 S Valley Mills Dr, Beverly Hills, TX 76711 Phone: 254-752-3986 |
Mahmud Hasanrafi Haque, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1520 S Valley Mills Dr, Beverly Hills, TX 76711 Phone: 254-752-3986 Fax: 254-752-4097 |
Mona Patel Petigara, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1513 S Valley Mills Dr, Beverly Hills, TX 76711 Phone: 254-756-1876 |
News Archive
Overweight or obesity increases lymphedema risk for breast cancer survivors
Throughout the world, 10 million breast cancer survivors have a lifetime risk for developing lymphedema, a chronic condition that involves swelling of the limbs and impacts physical and psychosocial health.
Degenerative process can be reversed by practicing regular aerobic exercise, shows study
Adipose tissue is not just a simple reservoir of energy for periods of food scarcity. It contributes significantly to regulation of the metabolism, releasing various molecules into the bloodstream, including microRNAs that modulate the expression of key genes in different parts of the organism, including the liver, pancreas, and muscles.
Drones can safely transport blood products without affecting cellular integrity, study shows
In what is believed to be the first proof-of-concept study of its kind, Johns Hopkins researchers have determined that large bags of blood products, such as those transfused into patients every day, can maintain temperature and cellular integrity while transported by drones.
Oncothyreon commences enrollment in PX-866 Phase 2 trial for metastatic castration-resistant prostate cancer
Oncothyreon Inc. today announced enrollment of the first patient in a Phase 2 trial of PX-866 in patients with recurrent or metastatic castration-resistant prostate cancer. PX-866 is a small molecule compound designed to inhibit the activity of phosphatidylinositol-3-kinase (PI-3K), a component of an important cell survival signaling pathway.
Enigma ML instrument system to be showcased at InnovHealth 2010 summit
Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today that it will be a product provider at the InnovHealth - Middle East Healthcare Innovations Summit in Abu Dhabi on 25 and 26 April 2010 and will be presenting the Enigma ("Mini Laboratory") instrument system.
› Verified 7 days ago